| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | OPTION TO PURCHASE COMMON SHARES | 75,000 | $52,500 | $0.7000 | 01 Jul 2025 | Direct |
| STAAR SURGICAL CO | Director, 10%+ Owner | OPTION TO PURCHASE COMMON STOCK | 7,524 | 06 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STAA | STAAR SURGICAL CO | 06 Mar 2026 | 1 | $0 | 4 | Director, 10%+ Owner | 10 Mar 2026, 19:13 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 03 Jul 2025, 14:45 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 03 Jul 2024, 14:00 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 03 Jul 2023, 16:23 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Jul 2022, 16:15 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 01 Jul 2021, 18:24 |
| LCTX | Lineage Cell Therapeutics, Inc. | 25 Jun 2021 | 2 | +$54,384 | 4 | Director, 10%+ Owner | 25 Jun 2021, 15:46 |